Fundz

Who to call at Lipella Pharmaceuticals, and when

Fundz watches for the moments Lipella Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Lipella Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lipella Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lipella Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Lipella Pharmaceuticals Closes $1.28 Million Direct Offering of Common Stock Under Nasdaq Rules

Aug 01, 2024

Contract Type

agreement

PittsburghBiotechnologyHealthcareHealth CareMedicalTherapeuticsPharmaceuticalBiopharma

Description

Lipella Pharmaceuticals Inc. has closed a registered direct offering priced at-the-market under Nasdaq rules, generating approximately $1.28 million in gross proceeds. The net proceeds from the offering will be allocated towards working capital and general corporate purposes.

Quick answer

Lipella Pharmaceuticals Closes $1.28 Million Direct Offering of Common Stock Under Nasdaq Rules (August 1, 2024). Lipella Pharmaceuticals is based in Pittsburgh, Pennsylvania, United States.

What agreement did Lipella Pharmaceuticals announce on August 1, 2024?
Lipella Pharmaceuticals Inc. has closed a registered direct offering priced at-the-market under Nasdaq rules, generating approximately $1.28 million in gross proceeds. The net proceeds from the offering will be allocated towards working capital and general corporate purposes.
What does Lipella Pharmaceuticals do?
Lipella is a biotechnology company with a focus on supportive care to cancer survivors who acquire hemorrhagic cystitis, also called radiation cystitis, when hemorrhagic cystitis occurs after pelvic radiation, as well...
Where is Lipella Pharmaceuticals based?
Lipella Pharmaceuticals is based in Pittsburgh, Pennsylvania, United States.

Source: Fundz verified event record.

Company Information

Company

Lipella Pharmaceuticals

Location

400 N Lexington Ave

Pittsburgh, Pennsylvania, United States

About

Lipella is a biotechnology company with a focus on supportive care to cancer survivors who acquire hemorrhagic cystitis, also called radiation cystitis, when hemorrhagic cystitis occurs after pelvic radiation, as well as improved surveillance and imaging of patients with a history of transitional cell carcinoma. We are also applying our proprietary drug delivery to the oral mucosa for the treatment of oral lichen planus.

Related People

Michael
Senior decision-maker at this company
••••••••@••••••••

See Michael's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Lipella Pharmaceuticals's next move

Learn about Strategic plan

Lipella Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.